Table 1 Demographic and clinical characteristics of the participants.

From: SLC25A24 gene methylation and gray matter volume in females with and without conduct disorder: an exploratory epigenetic neuroimaging study

Demographic & Clinical Characteristics

CD (n = 51)

TD (n = 59)

P (t-test)

Wilcoxon’s p

M

SD

M

SD

Demographic

      

Age

14.9

1.73

14.7

2.38

0.670

0.961

PDS

3.98

1.05

4.07

0.98

0.651

0.692

SES

−0.540

0.828

0.205

0.902

<0.001

<0.001

Total IQ

94.7

12.2

100.05

10.2

0.013

0.007

Perf. IQ

93.7

14.8

98.83

12.7

0.062

0.091

Verbal IQ

93.6

19.2

101.0

12.9

0.023

0.004

Clinical

ADHD symptoms

0.22

0.42

0.14

0.34

0.24

0.28

GAD symptoms

0.24

0.55

0

0.29

0.008

0.004

MDD symptoms

0.5

0.70

0

0

<0.001

<0.001

ICU total

29.6

11.4

17.6

9.02

<0.001

<0.001

ICU callous

10.2

5.38

4.65

3.80

<0.001

<0.001

ICU uncaring

13.1

5.27

8.37

4.54

<0.001

<0.001

ICU unemotional

6.31

3.59

4.93

2.74

0.030

0.040

  1. CD conduct disorder, TD typically developing, PDS Pubertal Development Scale, SES socio-economic status, IQ intelligent quotient, ADHD attention-deficit/hyperactivity disorder, GAD generalized anxiety disorder, MDD major depressive disorder, ICU inventory of callous-unemotional trait.